Sugi Predict

Sugi Predict / Compounds / SCHEMBL657290

SCHEMBL657290

SCHEMBL657290

O=C(O)CC(CC(=O)OC(=O)CC(CC(=O)O)c1ccccc1)c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ GABBR2 O75899 1/20 0.61
▸ GABBR1 Q9UBS5 1/20 0.61
▸ MAPT P10636 1/20 0.54
▸ MEN1 O00255 1/20 0.50
▸ KMT2A Q03164 1/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ RECQL P46063 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.49
▸ FNTA P49354 7/20 0.47
▸ FNTB P49356 7/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ PKM P14618 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ APEX1 P27695 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ POLB P06746 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9541616 1.00 GABBR2 (0.61) GABBR2GABBR1MAPTMEN1KMT2A
SCHEMBL658940 0.90 GABBR2 (0.50) GABBR2GABBR1MAPTMEN1KMT2A
SCHEMBL503819 0.88 GABBR2 (0.76) GABBR2GABBR1MAPTMEN1KMT2A
Hydrochloric Acid SCHEMBL7092228 0.86 GABBR2 (0.73) GABBR2GABBR1MAPTMEN1KMT2A
SCHEMBL6734410 0.86 GABBR2 (0.73) GABBR2GABBR1MAPTMEN1KMT2A
SCHEMBL12268202 0.85 ALDH1A1 (0.61) GABBR2GABBR1MAPTMEN1KMT2A
SCHEMBL1811811 0.85 ALDH1A1 (0.61) GABBR2GABBR1MAPTMEN1KMT2A
SCHEMBL657719 0.84 FNTA (0.50) GABBR2GABBR1MAPTMEN1KMT2A
SCHEMBL2471169 0.84 FNTA (0.50) GABBR2GABBR1MAPTMEN1KMT2A
SCHEMBL658678 0.84 FNTA (0.50) GABBR2GABBR1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118852022-B Gemini quaternary ammonium salt antibacterial agent, preparation thereof and application thereof in antibacterial polyester synthesis 浙江大学 2025-03-28 — — CN claimed
CN-118852022-A Gemini quaternary ammonium salt antibacterial agent, preparation thereof and application thereof in antibacterial polyester synthesis 浙江大学 2024-10-29 — — CN claimed
US-11912818-B2 Method for synthesizing aromatic-aliphatic copolyester without catalyst and product thereof ZHEJIANG UNIVERSITY (CN) 2024-02-27 — — US claimed
US-20230391948-A1 METHOD FOR SYNTHESIZING AROMATIC-ALIPHATIC COPOLYESTER WITHOUT CATALYST AND PRODUCT THEREOF ZHEJIANG UNIVERSITY (CN) 2023-12-07 — — US claimed
WO-2022148259-A1 METHOD FOR SYNTHESIZING AROMATIC-ALIPHATIC COPOLYESTER WITHOUT CATALYST, AND PRODUCT THEREOF 浙江大学 2022-07-14 — — WO claimed
US-9062155-B2 Organometallic catalyst and preparation thereof UNIVERSITY OF SYDNEY (AU) 2015-06-23 — — US claimed
US-20130331544-A1 ORGANOMETALLIC CATALYST AND PREPARATION THEREOF THE UNIVERSITY OF SYDNEY (AU) 2013-12-12 — — US claimed
US-8507708-B2 Organometallic catalyst and preparation thereof THE UNIVERSITY OF SYDNEY (AU) 2013-08-13 — — US claimed
US-20110319645-A1 ORGANOMETALLIC CATALYST AND PREPARATION THEREOF UNIVERSITY OF SYDNEY (AU) 2011-12-29 — — US claimed
WO-2010069000-A1 ORGANOMETALLIC CATALYST AND PREPARATION THEREOF THE UNIVERSITY OF SYDNEY (AU) 2010-06-24 — — WO claimed
CN-122071574-A Novel PEAT material 元素驱动(杭州)生物科技有限公司 2026-05-22 — — CN disclosed
WO-2025124564-A1 POLYESTER SYNTHESIS BASED ON ASPARTIC ACID MODIFICATION 元素驱动(杭州)生物科技有限公司 2025-06-19 — — WO disclosed
WO-2025108372-A1 TEMPERATURE-RESISTANT POLYMER AND PREPARATION METHOD THEREFOR, AND USE OF CYCLIC IMIDE DIOL COMPOUND 元素驱动(杭州)生物科技有限公司 2025-05-30 — — WO disclosed
WO-2025108371-A1 COPOLYMER WITH IMPROVED STRENGTH AND PREPARATION METHOD THEREFOR 元素驱动(杭州)生物科技有限公司 2025-05-30 — — WO disclosed
WO-2025021165-A1 POLYMER COMPRISING ESTER-IMIDE STRUCTURAL UNIT, AND PREPARATION METHOD THEREFOR 西湖大学 2025-01-30 — — WO disclosed
US-4962242-A HYDROGENATING OLEFINIC ALCOHOL USING AS CATALYST A RUTHENIUM-OPTICALLY ACTIVE PHOSPHINE COMPLEX TAKASAGO PERFUMERY CO., LTD. (JP) 1990-10-09 — — US disclosed
WO-1989011856-A2 CYCLIC LACTAMS FOR CHOLESTEROL AND ATHEROSCLEROSIS CONTROL THE UPJOHN COMPANY (US) 1989-12-14 — — WO disclosed
WO-1989011875-A1 CONTRAST AGENTS FOR MAGNETIC RESONANCE IMAGING OF THE SMALL INTESTINE AND HEPATOBILIARY SYSTEM THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1989-12-14 — — WO disclosed
US-4309541-A CHEMICAL INTERMEDIATES TO QUINAZOLINE HYPOTENSIVE AGENTS CIBA-GEIGY CORPORATION (US) 1982-01-05 — — US disclosed
US-4255429-A HYPOTENSIVE AGENTS CIBA-GEIGY CORPORATION (US) 1981-03-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319645-A1 ORGANOMETALLIC CATALYST AND PREPARATION THEREOF CA2, CA1, CA3 GABBR2 2577/4885GABBR1 3278/4885MAPT 3303/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.